Joseph Caprini to Anticoagulants
This is a "connection" page, showing publications Joseph Caprini has written about Anticoagulants.
Connection Strength
6.467
-
Venous thromboembolism prophylaxis using the Caprini score. Dis Mon. 2019 Aug; 65(8):249-298.
Score: 0.508
-
Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619838066.
Score: 0.507
-
Risk assessment as a guide for the prevention of cancer-associated thromboembolism. Int Angiol. 2018 Aug; 37(4):269-276.
Score: 0.482
-
Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication. Foot Ankle Spec. 2014 Dec; 7(6):507-14.
Score: 0.373
-
Current state of knowledge on oral anticoagulant reversal using procoagulant factors. Ann Pharmacother. 2013 Jun; 47(6):841-55.
Score: 0.344
-
Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Ann Surg. 2009 Aug; 250(2):219-28.
Score: 0.264
-
Implications of thromboprophylaxis registry data on clinical practice. Am J Med Sci. 2009 Jul; 338(1):58-63.
Score: 0.262
-
Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga. Thromb Haemost. 2008 Jun; 99(6):993-4.
Score: 0.244
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.241
-
Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005 Oct; 42(4):726-33.
Score: 0.202
-
Dissecting the rationale for thromboprophylaxis in challenging surgical cases. J Thromb Haemost. 2024 Mar; 22(3):613-619.
Score: 0.179
-
Calf deep venous thrombosis should be treated with anticoagulation. Med Clin North Am. 2003 Nov; 87(6):1157-64.
Score: 0.177
-
The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol. 2002 Mar; 21(1):78-85.
Score: 0.158
-
Thromboprophylaxis; what is the future, for high risk surgical patients? Phlebology. 2022 03; 37(2):81-83.
Score: 0.151
-
Finding the right fit: effective thrombosis risk stratification in orthopedic patients. Orthopedics. 2000 Jun; 23(6 Suppl):s633-8.
Score: 0.140
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
Score: 0.139
-
Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2020 06; 167(6):1025.
Score: 0.137
-
Deep vein thrombosis outcome and the level of oral anticoagulation therapy. J Vasc Surg. 1999 Nov; 30(5):805-11.
Score: 0.134
-
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999 Nov; 30(5):813-20.
Score: 0.134
-
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019 11; 17(11):1966-1972.
Score: 0.133
-
Venous thromboembolism controversies. Dis Mon. 2018 09; 64(9):408-444.
Score: 0.120
-
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 12; 117(12):2415-2424.
Score: 0.118
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27; 373(9):823-33.
Score: 0.099
-
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost. 1995; 21 Suppl 4:59-62.
Score: 0.096
-
Can combined (mechanical and pharmacological) modalities prevent fatal VTE? Int Angiol. 2011 Apr; 30(2):115-22.
Score: 0.074
-
Individual risk assessment is the best strategy for thromboembolic prophylaxis. Dis Mon. 2010 Oct; 56(10):552-9.
Score: 0.072
-
Venous thromboembolism in surgery--a preventable complication. Introduction. Am J Surg. 2010 Jan; 199(1 Suppl):S1-2.
Score: 0.068
-
Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010 Jan; 199(1 Suppl):S3-10.
Score: 0.068
-
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost. 2009 Jan; 101(1):77-85.
Score: 0.063
-
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev. 2008 Oct 08; (4):CD005258.
Score: 0.062
-
The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options. J Surg Oncol. 2007 Sep 01; 96(3):265-72.
Score: 0.058
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
Score: 0.058
-
Venous thromboembolism following major orthopedic surgery: what is the risk after discharge? Orthopedics. 2006 06; 29(6):506-16.
Score: 0.053
-
Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005 Jul 11; 165(13):1458-64.
Score: 0.050
-
Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes. 2003 Dec 15; 1:76.
Score: 0.045
-
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther. 2002 Nov; 24(11):1960-86; discussion 1938.
Score: 0.041
-
Thrombosis prophylaxis in surgical patients using the Caprini Risk Score. Curr Probl Surg. 2022 11; 59(11):101221.
Score: 0.041
-
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev. 2022 01 28; 1:CD005258.
Score: 0.039
-
Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord. 2021 07; 9(4):859-867.e2.
Score: 0.036
-
Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med. 2000 Feb 14; 160(3):334-40.
Score: 0.034
-
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620936350.
Score: 0.034
-
The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty. 1999 Dec; 14(8):988-93.
Score: 0.034
-
Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry. Clin Appl Thromb Hemost. 2017 Oct; 23(7):748-754.
Score: 0.027
-
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost. 1995; 21 Suppl 4:53-8.
Score: 0.024
-
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry. Clin Appl Thromb Hemost. 2014 Nov; 20(8):772-8.
Score: 0.023
-
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials. Thromb Res. 2012 Sep; 130(3):396-402.
Score: 0.020
-
In brief. Thromboembolic disease. Curr Probl Surg. 2008 Dec; 45(12):838-42.
Score: 0.016
-
Thromboembolic diseases. Curr Probl Surg. 2008 Dec; 45(12):844-99.
Score: 0.016
-
Venous thromboembolism and cancer. Curr Probl Surg. 2007 Mar; 44(3):157-216.
Score: 0.014
-
The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004 Nov; 2(11):1892-8.
Score: 0.012
-
Altered coagulability in cancer patients. CA Cancer J Clin. 1982 May-Jun; 32(3):162-72.
Score: 0.010
-
Altered coagulability in malignancy. IMJ Ill Med J. 1979 Nov; 156(5):384-90.
Score: 0.008
-
Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg. 1996 Apr; 23(4):616-21.
Score: 0.007
-
Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost. 1995; 21 Suppl 4:21-6.
Score: 0.006
-
Application of thromboelastography in other medical and surgical states. Semin Thromb Hemost. 1995; 21 Suppl 4:50-2.
Score: 0.006
-
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol. 1992 Jul-Sep; 11(3):151-9.
Score: 0.005